Hib CRM197 vaccine conjugate

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameHib CRM197 vaccine conjugate
Drug Alias Namebๅž‹ๆตๆ„Ÿๅ—œ่ก€ๆ†่ŒCRM197่žๅˆ็–ซ่‹—bๅž‹ๆตๆ„Ÿๅ—œ่ก€ๆ†่ŒCRM197็ป“ๅˆ็–ซ่‹—HibTITERMT-2301NU-300
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCommunicable DiseasesHaemophilus InfectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesPfizer IncNuron Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma CorpNuron Biotech IncWyeth Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCommunicable DiseasesHaemophilus InfectionsInfluenza B virus infection

Other Information

ATC CodeJ07AG01
Related LinksN/A